🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

SURG SURG

Company Profile ↓
$0.22
-91.73% 1Y
Mkt Cap$4.81M
P/E-0.12
P/B-0.31
52W High$3.05
52W Low$0.21
Book Value$-0.70
EPS (TTM)$-1.80

Company Overview

SURG (SURG) is a publicly traded company listed on with a market capitalization of $4.81M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 134.2% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $56.96M (-6.4% YoY); net profit $-36.07M.
  • Trailing 12 Months Year-on-year growth — revenue -6.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 134.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:134.18%
1 Year:-6.44%

Stock Price Performance

1 Year:-91.73%
6 Months:-79.31%
3 Months:-59.01%
1 Month:-45.51%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
$0.21 $3.05
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)32.36 · Neutral
Price Performance
1M-45.51%
3M-59.01%
6M-79.31%
1Y-91.73%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 134.2% over 5 years.

CONS

  • Trading 92.7% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.12
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-0.70
Price to Book
-0.31
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
134.18%
Profit 5Y
-
Revenue (YoY)
-6.44%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
-63.32%
Op Margin
-53.82%
Gross Margin
-18.59%
EPS (Latest Qtr)
$-0.51
EPS (TTM)
$-1.80

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
0.37
Current Ratio
0.38
Debt
$13.58M
Total Assets
$9.50M
Current Assets
$8.21M
Working Capital
$-11.21M

Ownership

Promoter Holding
37.04%
Chg in Prom Hold
-
FII / Inst Holding
9.22%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$56.96M
EBITDA
$-32.95M
Free Cash Flow
$-21.31M
Operating Cash Flow
$-21.29M
Shares Outstanding
21.85M
Gross Margin
-18.59%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jan 2014Jul 2014Oct 2014Jan 2015Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------------3.43M4.05M4.05M3.94M3.45M4.90M15.79M14.51M12.80M10.99M11.38M14.54M21.14M28.01M36.17M34.78M35.89M34.16M31.43M15.09M4.77M-10.58M11.52M18.68M16.19M15.98M
Cost of Revenue -----------------------------------13.52M14.17M21.28M18.58M23.68M
Gross Profit ----308.64K210.76K174.24K337.85K227.13K233.83K298.98K1.13M1.39M1.68M1.89M1.81M1.46M1.14M1.88M728.88K132.97K1.59M1.13M1.33M------------2.94M-2.65M-2.60M-2.40M-7.70M
Operating Expenses -----------------------------------4.64M4.16M4.35M6.92M3.50M
Operating Income -18.37K-12.06K-8.29K-4.12K-27.22K-182.60K-185.11K-579.41K-1.03M-516.98K-769.30K7.14K48.27K408.52K-192.19K-399.81K-1.11M-2.53M-1.14M-2.77M-4.03M-1.62M-2.11M-1.41M-1.01M-1.05M-847.54K-1.01M4.71M6.20M7.09M1.75M-10.88M-14.28M--7.58M-6.81M-6.95M-9.32M-11.20M
EBITDA ------------------------------------7.21M-6.51M-6.70M-12.54M-10.93M
Interest Expense -----------------------------------119.43K279.31K539.16K1.07M881.91K
Pretax Income ------------------------------------7.64M-7.08M-7.49M-13.86M-12.05M
Tax Provision -----------------------------------00000
Net Income -28.80K-26.46K-30.60K-26.43K-29.55K-184.59K-186.87K-614.64K-1.10M-878.87K-967.58K1.60K2.59M401.00K-375.12K-425.72K-1.64M-2.47M-1.15M-3.06M-2.43M-2.50M-4.82M-213.98K-1.66M-1.21M-973.04K-1.54M4.55M5.97M7.08M1.22M-12.87M-14.28M--7.64M-7.08M-7.49M-13.86M-12.05M
Diluted EPS --------------------------0.10-0.08-0.120.310.400.490.07-0.66-0.73--0.38-0.36-0.38--0.51

Profit & Loss (Annual)

Figures in USD.

Metric Apr 2008Apr 2009Apr 2010Apr 2011Apr 2012Apr 2013Apr 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ----2.09K1.45K1.88K2.83M3.30M13.46M15.24M25.74M54.41M-121.54M137.14M60.88M56.96M
Cost of Revenue --------------108.07M101.50M75.21M67.55M
Gross Profit -------500.66K968.28K5.36M6.67M3.12M2.47M-13.47M35.64M-14.32M-10.59M
Operating Expenses --------------12.84M16.78M27.46M20.07M
Operating Income -----651.94K-36.46K-49.48K-1.32M-3.11M204.28K-1.54M-7.77M-10.15M-626.02K18.87M-41.78M-30.66M
EBITDA --------------2.39M20.08M-41.22M-32.95M
Interest Expense --------------1.96M595.98K554.20K2.00M
Pretax Income ---------------553.23K18.38M-43.07M-36.07M
Tax Provision --------------0-2.27M2.87M0
Net Income -24.80K-1.10M-1.38M-462.39K-655.45K-62.29K-55.62K-1.34M-4.60M2.77M-1.54M-8.45M-10.72M--680.76K20.62M-45.73M-36.07M
Diluted EPS ---------------0.051.38-2.39-1.80

Balance Sheet (Annual)

Figures in USD.

Metric Apr 2007Apr 2008Apr 2009Apr 2010Apr 2011Apr 2012Apr 2013Apr 2014Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -----2.86K2.79K2.60K1.46M2.63M2.36M3.08M4.08M9.99M7.33M-34.00M41.93M23.98M8.52M
Current Assets ----------------27.56M33.37M17.87M6.98M
Cash & Equivalents ----71631648232237.82K69.49K439.27K1.27M444.61K346.04K674.00K-7.04M14.62M11.79M1.73M
Inventory ----------------11.19M9.05M1.78M339.57K
Receivables ----------------9.23M9.54M3.00M4.05M
Total Liabilities --------1.43M3.23M4.17M3.69M6.07M14.69M18.05M-28.89M13.52M8.71M23.92M
Current Liabilities -----771.57K833.80K889.23K635.29K2.60M4.06M2.81M4.79M7.05M15.66M-23.46M12.71M6.06M18.19M
Long Term Debt --------794.94K555.94K58.65K52.19K680.00K2.21M1.12M-5.02M460.52K2.34M5.63M
Total Debt ----------------8.11M5.44M4.59M13.58M
Total Equity 114.62K89.82K-237.60K-286.67K-113.27K-768.72K-831.00K-886.63K33.08K-606.75K-3.38M-617.24K-1.99M-4.70M-10.73M-4.99M28.25M15.32M-15.35M
Shares Outstanding ----------------14.12M14.40M20.43M21.85M

Cash Flows (Annual)

Figures in USD.

Metric Apr 2012Apr 2013Apr 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -357.72K-73.58K-44.95K-224.52K-641.88K227.80K-1.02M-6.53M-4.33M-793.27K10.29M-21.31M-21.29M
Investing Cash Flow -0018.33K-503.00K-147.00K-278.04K-32.24K8.35K--1.50M-281.30K-3.00M-18.59K
Financing Cash Flow 357.32K73.74K44.79K237.86K1.14M607.09K464.10K6.47M4.65M-1.46M-2.42M22.48M10.53M
Capital Expenditure ----9.73K-3.00K-147.00K-331.80K-227.63K-6.61K--698.58K-281.30K-518.19K-18.59K
Free Cash Flow ----234.25K-644.88K80.80K-1.35M-6.76M-4.33M-94.69K10.01M-21.83M-21.31M
Net Change in Cash ----------752.16K7.59M-1.83M-10.78M
Share Buybacks --------500.00K-----

Ratios (Annual)

Figures in %.

Metric Apr 2008Apr 2009Apr 2010Apr 2011Apr 2012Apr 2013Apr 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------17.7%29.4%39.9%43.8%12.1%4.5%-11.1%26.0%-23.5%-18.6%
Operating Margin % -----31,133.7%-2,512.8%-2,638.8%-46.6%-94.2%1.5%-10.1%-30.2%-18.6%-0.5%13.8%-68.6%-53.8%
Net Margin % -----31,301.3%-4,292.8%-2,966.6%-47.2%-139.5%20.6%-10.1%-32.8%-19.7%--0.6%15.0%-75.1%-63.3%
ROE % -27.6%461.9%482.4%408.2%85.3%7.5%6.3%220.2%136.1%-448.4%77.5%179.7%100.0%--13.6%73.0%-298.6%235.0%
ROCE % ----84.8%4.4%5.6%-4,430.5%182.5%76.7%217.0%-264.9%121.7%-5.9%64.6%-233.2%316.9%

Shareholding Pattern

Insiders
37.04%
Institutions
9.22%
Public Float
14.64%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SURG

Google News Wed, 05 Aug 2026

New wireless venture gets access to 20,000 prepaid dealers - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPNEtQUjBZQlRta2ZSNWRQUVBEWnpyUy1UeXhTUFRvVXRld3JRWEZIbnhORklkcHluWG5DbDk2VmszSDduWnRNcy1lRzFya2RqOTZUUGU2N0FJSFBUanFtZjZfU3d1QkdOZU00OU9iWm5KYkdwSW9ZS1BpcmlTSzBNVEltMXl6ekI0ZjN1VW…

Google News hu, 30 Jul 2026

SurgePays, Inc. (SURG) Stock Rises on Q1 2026 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPTHpFVVZEU1ZUQk00bTNDcW1TU3ZHMVFXQ0xkeF85UVVIX2VXbmRJM1BtbThwZVdaR3Fsb3hEaEozdTJKM09VcEx2NnA0bFpRNHUyWmJsYW5tOW12MktTR0pJcWY1UC1NdzkzLVg2ZXl5Qi1FZkZqZ0pnWlBIZ3hTUy13UFdaYnlfZ2IxNk…

Google News Sat, 18 Jul 2026

Why Intuitive Surgical Stock Dropped This Week - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOajctekdrbUJCZlhrZFNuMHhQYXVGOWhKVkJDNENiYXBpYi1vTnJRNHNRb2EzdHdGSTRRdVdtSzk2OWZEaEFkaldwa1BXQi1QbldxMkh0dGMyZXZxUWE5eGJpdDBramFhczk0emR2enJxYW9rdG5oTzBhbC1LZzc0UVVoSW1RdW5XUTNsVF…

Google News Wed, 22 Jul 2026

Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today - Barchart.com

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRVdfSGhsbmV2YlhSWGJBMXA2RjBXWC1BaTNoMF9idlBjd3pldXRxYmQyenVlTmlKblRZOG9QLVVBOXpIRG5faHhBd3JBQ2JfRXAxdmZfOTBEVmZnNWh5OFJhR2o3TDEyZ21nVjEtYjU3Szl0SmI5dGVDUm1xUkp0OWVoQ21zYmtfaVpGVE…

Google News hu, 30 Jul 2026

SurgePays Subsidiary Torch Wireless Challenges FCC Forfeiture Notice - theglobeandmail.com

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxPb2ZZWUVRYXJlU3hZR2NhMG5zWFZ4aVJ6bUFOeUhIblpXSm9IckFWdTRtUUZ3eldpdVhzRnJGeHNrUnZvX2FnMFNVT1hrZWRCb2hMb0dqVjhmRGdBTGptR3RkaGtBamhNQlhFTFI3ajh3bERjMWpvYlV5U2tFYm1lMWRTN3Q5UDBwS1ZVSk…

Google News ue, 14 Jul 2026

Here's Exactly Why Intuitive Surgical Stock Is Floundering in 2026 - The Motley Fool

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOYlJiWEhNRTFmX2ExX3dRdGJpYzNlRENPTHZId1d3QTI0QkZ2dE0yYjVNYjlhamo4MWVPSklyd0dEU285V0dqZ19FZWc4U2ZXMFJ4NDdkV3A1eHRpY1pXZFdSNGc2ZC1qd3B0WUdUNnFYeGdwelNod1pDQjk4b2d6bVRvTnFHazMwUlhyQz…

SURG — Frequently Asked Questions

What is the current share price of SURG?

As of 2026-08-05 17:25 PDT, SURG trades at $0.22 on NASDAQ/NYSE. Its 52-week range is $0.21 to $3.05.

What is the market capitalisation of SURG?

SURG has a market capitalisation of $4.81M on NASDAQ/NYSE.

What is the P/E ratio of SURG?

SURG trades at a trailing price-to-earnings (P/E) ratio of -0.12. Its price-to-book (P/B) ratio is -0.31.

Is SURG a good stock to buy?

This page provides a data-driven analysis of SURG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space